New York City-based Brightstar Capital Partners announced on August 4 that it acquired Analyte Health.
Analyte Health is a leading national company empowering patients to acquire and understand healthcare diagnostic information. By combining a national network of patient service diagnostic centers, a family of online digital assets and a national telehealth footprint, Analyte Health has delivered more than 2.2 million test results since its inception in 2007.
Brightstar Capital Partners is a middle market private equity firm with more than $4 billion assets under management that is focused on investing in business services, industrials, consumer and government services and technology.
As part of the transaction, Analyte founder Fiyyaz Pirani will continue as CEO and retain a significant ownership stake in Analyte.
J.P. Morgan Securities LLC served as exclusive financial advisor and Kirkland & Ellis LLP served as legal advisor to Brightstar. Intrepid Investment Bankers LLC served as financial advisor and Kastner Gravelle LLP as legal advisor to Analyte.
According to data captured in the LevinPro HC database, this transaction represents the 183rd eHealth acquisition of 2025, and the 29th in the telehealth specialty. There were 42 telehealth transactions reported in 2024.
